Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology.
Fiche du document
- doi: 10.1016/j.esmoop.2021.100237
- issn: 2059-7029
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2021.100237
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/34411971
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2059-7029
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4A3F20502CAC3
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Mots-clés
COVID-19; Humans; Medical Oncology; Pandemics/prevention & control; SARS-CoV-2; TelemedicineSujets proches
Telemedicine Telecare (Medicine) People Man Humanity (Human beings) Human race Mankind Homo sapiens Humankind HumansCiter ce document
L. Castelo-Branco et al., « Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology. », Serveur académique Lausannois, ID : 10.1016/j.esmoop.2021.100237
